Search for: "Impax Laboratories, Inc"
Results 1 - 20
of 78
Sort by Relevance
|
Sort by Date
27 Aug 2023, 6:27 pm
Endo Pharmaceuticals Inc., No. 22-5137. [read post]
27 Aug 2023, 6:27 pm
Endo Pharmaceuticals Inc., No. 22-5137. [read post]
27 Oct 2021, 5:15 am
(functional trade dress); Impax Laboratories, Inc. v. [read post]
15 Oct 2021, 9:43 am
” Impax Laboratories, Inc. v. [read post]
30 Apr 2018, 10:30 am
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
22 Feb 2017, 7:44 am
The FTC also announced that, in a related matter, it had filed an administrative complaint targeting a similar reverse-payment agreement to delay entry of a generic medication with California-based drugmaker Impax Laboratories (NASDAQ:IPXL). [read post]
9 Jan 2017, 9:36 am
Ct. 831 (2015).But see also Teva loses on 40mg Copaxone (for MS) at PTAB Separately, from NASDAQ.com on 9 January 2017:Impax Laboratories, Inc. [read post]
18 May 2016, 9:56 pm
Impax Laboratories, Inc. 2:16-cv-02526; filed May 6, 2016 in the District Court of New Jersey Infringement of U.S. [read post]
18 Apr 2016, 12:49 pm
The FTC’s complaint alleges that Endo engaged in a pay for delay scheme by paying the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
24 Sep 2015, 8:43 am
On August 10th, the rights to sell Daraprim were bought from Impax Laboratories Inc. [read post]
24 Sep 2015, 8:43 am
On August 10th, the rights to sell Daraprim were bought from Impax Laboratories Inc. [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
2 Jun 2013, 8:40 pm
• Defendant: Impax Laboratories, Inc. [read post]
6 Feb 2013, 4:43 pm
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
3 Feb 2013, 8:26 pm
Laboratories, Inc.; Purdue Pharmaceuticals L.P.; Rhodes Technologies • Defendant: Impax Laboratories, Inc.... [read post]
21 Jan 2013, 7:27 am
Food and Drug Administration said Wednesday the product, Budeprion XL 300 milligrams, which is manufactured by Impax Laboratories Inc. and marketed by Teva Pharmaceuticals USA Inc., "is not therapeutically equivalent to Wellbutrin XL 300 mg" or the extended-release version of Wellbutrin.In a post titled A Drug Recall That Should Frighten Us All About The FDA The People’s Pharmacy, a well-known syndicated radio and newspaper columnist husband and wife team,… [read post]
